MGMT and glioblastoma: This phenomenon might contribute to improved antitumor effects of radiotherapy or chemotherapy upon co-administration with CIL [26, 66], and the clinical benefit apparently observed in some GBM patients with MGMT promoter methylation in a phase III clinical trial, in which CIL was added to standard chemoradiotherapy [67].